Medical Devices
FDA Moves to Class II Designation for Prognostic Assessment Software Targeting Mild Cognitive Impairment
The U.S. Food and Drug Administration announced that it intends to classify software used to prognostically assess mild cognitive impairment as a Class II medical device, subject to special controls. The agency…
1 source4 claims checked11d ago
4 unverifiable
Biblical perspectiveINSUFFICIENT CONTEXT
Full analysis